The US Patent & Trademark Office (USPTO) has issued a notice of allowance for Elorac's patent application regarding novel acne therapy. The US patent is entitled "Method and Composition for Treating Nodulocystic and Conglobate Acne ...
Tags: Acne Therapy, Medicine
Biopharmaceutical company Soligenix has secured a contract worth $6.4m from the US Department of Health and Human Service's National Institutes of Health (NIH), for the advanced preclinical development of OrbeShield (oral beclomethasone ...
Luminex, a biotechnology company, has obtained the US Food and Drug Administration (FDA) and European approvals for a new personalized medicine genotyping assay, xTAG CYP2C19 kit. xTAG CYP2C19 kit is a comprehensive genotyping assay that ...
Tags: Genotyping Assay, Luminex
Integra LifeSciences, an integrated medical technology company, has announced the first US implantation of its Integra Titan reverse shoulder system, which is designed for use in the treatment of shoulder replacement surgery. Integra ...
Tags: Integra LifeSciences, Medicine
The US Food and Drug Administration (FDA) has finalized a new rule for the unique device identification (UDI) system, designed to provide a consistent and clear way to identify medical devices. The FDA worked jointly with industry, ...
Tags: Unique Device, Medicine
Swiss drugmaker F. Hoffmann-La Roche has announced that the EU’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending authorization of Kadcyla as a single agent for the treatment of adult ...
Tags: Breast Cancer Drug
Accelrys, a US-based provider of lifecycle management solutions, has completed the roll-out of its next-generation cheminformatics suite, with the launch of Accelrys Insight and Accelrys Insight for Excel. Both the solutions will help in ...
Tags: lifecycle management, Medicine
British drugmaker AstraZeneca has received positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) for its new four-in-one flu vaccine Fluenz Tetra. Fluenz Tetra, a nasally ...
Tags: Astrazeneca, Medicine
US-based Sapheon has submitted the first module of pre-market approval (PMA) application to the US Food and Drug Administration (FDA) for its VenaSeal sapheon closure system, designed to treat venous reflux (varicose veins) disease. This ...
Tags: PMA Application, Medicine
The US Food and Drug Administration’s (FDA) Ophthalmic Devices Panel announced that Ocular Therapeutix’s ReSure sealant is safe and effective in managing clear corneal wound leaks following cataract surgery. ReSure Sealant is ...
Tags: Ocular Therapeutix, Medicine
Tianjin Zhongxin Pharmaceutical Group Corporation Limited (SHSE: 600329) revealed that a notice has been received from controlling shareholder Tianjin Jinhao Pharmaceutical Co., Ltd., saying that agreement has been inked with controlling ...
Medical device company Teleflex has introduced ARROW JACC (jugular axillo-subclavian central catheter), a small-french size antimicrobial and antithrombogenic catheter designed for both acute and long-term use, with Chlorag+ard technology. ...
A multiple-sclerosis drug that was at the center of Sanofi SA's SAN.FR +1.12% $20 billion takeover battle for Genzyme Corp. three years ago was approved for sale in Europe on Tuesday, the drug's first regulatory approval world-wide. The ...
Amerinet, a national healthcare solutions organization, has signed an agreement with All Medical Solutions (AMS), the Healthcare division of Fusion Systems North America, to make the AMS SPHER, a health insurance portability and ...
The US Food and Drug Administration (FDA) has accepted to review AstraZeneca's new drug application (NDA) for Epanova, an investigational compound for the treatment for patients with severe hypertriglyceridaemia. Omthera Pharmaceuticals, ...